These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1320 related articles for article (PubMed ID: 25857211)

  • 61. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.
    Calder PC
    Biochim Biophys Acta; 2015 Apr; 1851(4):469-84. PubMed ID: 25149823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endogenous receptor agonists: resolving inflammation.
    Bannenberg G; Arita M; Serhan CN
    ScientificWorldJournal; 2007 Sep; 7():1440-62. PubMed ID: 17767360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipid signaling in adipose tissue: Connecting inflammation & metabolism.
    Masoodi M; Kuda O; Rossmeisl M; Flachs P; Kopecky J
    Biochim Biophys Acta; 2015 Apr; 1851(4):503-18. PubMed ID: 25311170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes.
    Shivakoti R; Dalli J; Kadam D; Gaikwad S; Barthwal M; Colas RA; Mazzacuva F; Lokhande R; Dharmshale S; Bharadwaj R; Kagal A; Pradhan N; Deshmukh S; Atre S; Sahasrabudhe T; Kakrani A; Kulkarni V; Raskar S; Suryavanshi N; Chon S; Gupte A; Gupta A; Gupte N; Arriaga MB; Fukutani KF; Andrade BB; Golub JE; Mave V
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106398. PubMed ID: 31726221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipid Mediators in Inflammation.
    Bennett M; Gilroy DW
    Microbiol Spectr; 2016 Nov; 4(6):. PubMed ID: 27837747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Towards targeting resolution pathways of airway inflammation in asthma.
    Barnig C; Frossard N; Levy BD
    Pharmacol Ther; 2018 Jun; 186():98-113. PubMed ID: 29352860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
    Serhan CN
    Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration.
    Serhan CN; Chiang N
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106718. PubMed ID: 36813255
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
    Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch.
    Schmid T; Brüne B
    Front Immunol; 2021; 12():714042. PubMed ID: 34322137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
    Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
    Recchiuti A; Mattoscio D; Isopi E
    Front Pharmacol; 2019; 10():252. PubMed ID: 31001110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of specialized pro-resolving mediators in maternal-fetal health.
    Elliott E; Hanson CK; Anderson-Berry AL; Nordgren TM
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():98-104. PubMed ID: 29031403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
    FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.